Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
3 hedge funds and large institutions have $950K invested in Innovator IBD ETF Leaders ETF in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
47% less capital invested
Capital invested by funds: $1.78M → $950K (-$834K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$850K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.3M |
| 2 |
LPL Financial
San Diego,
California
|
-$356K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$46K |
LDRS Hedge Fund Activity: Q2 2021 in Review
3 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q2 2021, worth a combined $950K — down 47% from $1.78M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LDRS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $850K. The largest seller was Old Mission Capital, exiting entirely with an estimated $1.3M sold.
- 3 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q2 2021, down from 4 in Q1 2021.
- Funds reported $950K of Innovator IBD ETF Leaders ETF stock for Q2 2021, down 47% quarter-over-quarter.
- 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q2 2021 and 2 closed out, a net change of -1 holder.
- The largest Innovator IBD ETF Leaders ETF buyer in Q2 2021 was Susquehanna International Group, an estimated $850K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q2 2021 was Old Mission Capital, an estimated $1.3M sold.
Based on aggregated 13F filings for Q2 2021.